| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e1c56b88229114d57f1a0050eb922f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4822917332cc6b922e43d584b64409fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_caaff361485c8bfeff5890df188809cf |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 |
| filingDate |
2010-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77a81c0c30fe01cea0c08638fb7893ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c179995a68de5113711f7a5457164ba4 |
| publicationDate |
2012-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8252330-B2 |
| titleOfInvention |
Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen |
| abstract |
In one aspect, the present invention features a tablet including a first drug layer and a second drug layer, wherein: (i) the first drug layer includes first drug particles including naproxen and third drug particles including cetirizine, where the first drug particles and/or the third drug particles are coated with an immediate release coating; and (ii) the second drug layer including pseudoephedrine, wherein said second drug layer is a sustained release layer adapted to deliver a therapeutically effective amount of pseudoephedrine for a period of at least twelve hours. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11433030-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10576041-B2 |
| priorityDate |
2009-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |